UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.82 +0.80 (+1.03%) GOLD FUTURES
2,392.40 +32.50 (+1.38%) DOW
39,928.04 +369.93 (+0.94%) Bitcoin GBP
52,030.84 +3,499.98 (+7.21%)
Astellas Pharma Inc. (YPH.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:15AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 16.17B |
| Enterprise value | 19.64B |
| Trailing P/E | 560.13 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.74 |
| Price/book (mrq) | 1.77 |
| Enterprise value/revenue | 2.15 |
| Enterprise value/EBITDA | 19.74 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.31 |
| 52-week change 3 | -40.18% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 15.61 |
| 52-week low 3 | 8.53 |
| 50-day moving average 3 | 9.33 |
| 200-day moving average 3 | 11.08 |
Share statistics
| Avg vol (3-month) 3 | 160 |
| Avg vol (10-day) 3 | 120 |
| Shares outstanding 5 | 1.79B |
| Implied shares outstanding 6 | 1.84B |
| Float 8 | 1.79B |
| % held by insiders 1 | 0.25% |
| % held by institutions 1 | 51.30% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.45 |
| Forward annual dividend yield 4 | 5.06% |
| Trailing annual dividend rate 3 | 70.00 |
| Trailing annual dividend yield 3 | 795.27% |
| 5-year average dividend yield 4 | 2.76 |
| Payout ratio 4 | 2,452.83% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 27 Sept 2024 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 27 Mar 2014 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 1.06% |
| Operating margin (ttm) | -7.98% |
Management effectiveness
| Return on assets (ttm) | 1.80% |
| Return on equity (ttm) | 1.10% |
Income statement
| Revenue (ttm) | 1.6T |
| Revenue per share (ttm) | 894.27 |
| Quarterly revenue growth (yoy) | 17.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 244.7B |
| Net income avi to common (ttm) | 17.05B |
| Diluted EPS (ttm) | 0.02 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 335.69B |
| Total cash per share (mrq) | 187.23 |
| Total debt (mrq) | 920.02B |
| Total debt/equity (mrq) | 57.65% |
| Current ratio (mrq) | 0.93 |
| Book value per share (mrq) | 890.18 |
Cash flow statement
| Operating cash flow (ttm) | 172.48B |
| Levered free cash flow (ttm) | 109.61B |
© 2024 Yahoo. All rights reserved.